Zogenix to Present at Leerink Swann 2014 Global Healthcare Conference

Zogenix to Present at Leerink Swann 2014 Global Healthcare Conference

SAN DIEGO, Feb. 4, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a
pharmaceutical company developing and commercializing products for the
treatment of central nervous system disorders and pain, today announced that
Stephen J. Farr, Ph.D., President, and Ann Rhoads, Chief Financial Officer,
will be presenting at the Leerink Swann 2014 Global Healthcare Conference in
New York on February 12, 2014.

  Event: Leerink Swann 2014 Global Healthcare Conference

  Date: Wednesday, February 12, 2014

  Place: New York City

  Time: 2:40 pm ET/ 11:40 am PT

The presentation will be webcast live and archived for 30 days on Zogenix'
Investor Relations website at ir.zogenix.com. Dr. Farr and Ms. Rhoads will
also be available to participate in one-on-one meetings at the conference.

About Zogenix

Zogenix, Inc. (Nasdaq:ZGNX), with offices in San Diego and Emeryville,
California, is a pharmaceutical company committed to developing and
commercializing therapies that address specific clinical needs for people
living with pain-related conditions and central nervous system disorders who
need innovative treatment alternatives to help them return to normal daily
functioning. The Company has commercialized two products using technology to
enhance the patient experience and has a development pipeline that includes a
once-monthly subcutaneous injection for schizophrenia. More information about
Zogenix is available at www.zogenix.com

                                     FPR

CONTACT: INVESTORS:
         Zack Kubow | The Ruth Group
         646.536.7020 | zkubow@theruthgroup.com
        
         MEDIA:
         Amy Wheeler | The Ruth Group
         646.536.7025 | awheeler@theruthgroup.com
 
Press spacebar to pause and continue. Press esc to stop.